Evidence map›Paper›PMID 34638717›Full record

ArticleInternational journal of molecular sciences2021

Atrial Fibrillation in Heart Failure Is Associated with High Levels of Circulating microRNA-199a-5p and 22-5p and a Defective Regulation of Intracellular Calcium and Cell-to-Cell Communication.

Anna Garcia-Elias, Marta Tajes, Laia Yañez-Bisbe, Cristina Enjuanes, Josep Comín-Colet, Selma A Serra, José M Fernández-Fernández, Kathryn W Aguilar-Agon, Svetlana Reilly, Julio Martí-Almor and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Optogenetic tachypacing facilitates burst-induced arrhythmia in stem cell-derived human atrial engineered heart tissue.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Perspective and Therapeutic Potential of the Noncoding RNA-Connexin Axis.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Non-coding RNA and arrhythmias: expression, function, and molecular mechanism.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  12. Article
  13. Research progress of non-coding RNA in atrial fibrillation.Frontiers in cardiovascular medicine · 2023
    Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Anna Garcia-EliasVascular Biology and Metabolism Program, Vall d'Hebron Research Institute (VHIR), Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Marta TajesGroup of Biomedical Research in Heart Diseases, Hospital del Mar Medical Research Institute (IMIM), Doctor Aiguader 88, 08003 Barcelona, Spain.
Laia Yañez-BisbeVascular Biology and Metabolism Program, Vall d'Hebron Research Institute (VHIR), Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Cristina EnjuanesResearch Group in Cardiovascular Disorders (BIOHEART), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.
Josep Comín-ColetResearch Group in Cardiovascular Disorders (BIOHEART), Bellvitge Biomedical Research Institute (IDIBELL), Avinguda de la Granvia de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Spain.
Selma A SerraLaboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain.
José M Fernández-FernándezLaboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain.ORCID 0000-0003-2330-8449
Kathryn W Aguilar-AgonRadcliffe Department of Medicine, Division of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0003-3840-0731
Svetlana ReillyRadcliffe Department of Medicine, Division of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Julio Martí-AlmorGroup of Biomedical Research in Heart Diseases, Hospital del Mar Medical Research Institute (IMIM), Doctor Aiguader 88, 08003 Barcelona, Spain.ORCID 0000-0001-9927-1190
Begoña BenitoVascular Biology and Metabolism Program, Vall d'Hebron Research Institute (VHIR), Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Bellvitge University Hospital · ESJohn Radcliffe Hospital · GBUniversitat Autònoma de Barcelona · ESUniversitat Pompeu Fabra · ESVall d'Hebron Institut de Recerca · ES

Funding

British Heart Foundation FS/16/5/32054Instituto de Salud Carlos III PI13/01830Ministerio de Ciencia e Innovación RTI2018-094809-B-I00Sociedad Española de Cardiología Arritmias y Electrofisiología 2012Sociedad Española de Cardiología Insuficiencia Cardíaca 2013Societat Catalana de Cardiologia Arrítmies 2013
6 · The paper itself

Abstract

MicroRNAs (miRNAs) participate in atrial remodeling and atrial fibrillation (AF) promotion. We determined the circulating miRNA profile in patients with AF and heart failure with reduced ejection fraction (HFrEF), and its potential role in promoting the arrhythmia. In plasma of 98 patients with HFrEF (49 with AF and 49 in sinus rhythm, SR), differential miRNA expression was determined by high-throughput microarray analysis followed by replication of selected candidates. Validated miRNAs were determined in human atrial samples, and potential arrhythmogenic mechanisms studied in HL-1 cells. Circulating miR-199a-5p and miR-22-5p were significantly increased in HFrEF patients with AF versus those with HFrEF in SR. Both miRNAs, but particularly miR-199a-5p, were increased in atrial samples of patients with AF. Overexpression of both miRNAs in HL-1 cells resulted in decreased protein levels of L-type Ca

Indexed as

Calcium SignalingCell CommunicationAgedAged, 80 and overAtrial FibrillationCell LineCirculating MicroRNAFemaleHeart FailureHumansMaleMicroRNAsCirculating MicroRNAMicroRNAsmirn199 microRNA, humanMIRN22 microRNA, humanatrial fibrillationatrial remodelingbiomarkerscalcium regulationconnexin 40heart failureHL-1 cellsL-type calcium channelsmicroRNANCX1

Identifiers

PMID34638717
PMCPMC8508749
OpenAlexW3202050123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.